Overview

Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this pilot study is to compare the analgesic effect of two strengths of SYL1001 eye drops versus placebo in patients with ocular pain associated with Dry Eye Syndrome. General and local tolerability are also evaluated.
Phase:
Phase 2
Details
Lead Sponsor:
Sylentis, S.A.
Treatments:
Ophthalmic Solutions
Tetrahydrozoline